East Asia, particularly China and Japan, is expected to be the key growth region with growth rates of 15.4% and 12.0%, respectively
Rybelsus, an oral semaglutide drug, is one of many treatments used to target type 2 diabetes
In the U.S., CMS guidance from March 2024 allows Medicare Part D coverage of AOMs with medically accepted indications, such as diabetes or reducing the risk of major adverse cardiovascular events in patients with established cardiovascular disease
Semaglutide Weight Loss Success Stories: Real Results from Real People Imagine if there was a treatment that could really help with weight loss
[DOI] [PMC free article] [PubMed] [Google Scholar] 1017
Low-dose aspirin (typically 81 mg daily in the US) should be considered for secondary prevention in patients with prior cardiovascular events, while primary prevention use requires individualized assessment of bleeding risk versus benefit